TC-325 (HEMOSPRAY™) VS. CURRENT STANDARD OF CARE IN MANAGING MALIGNANT GASTROINTESTINAL BLEEDING: A PILOT STUDY TO INFORM A RANDOMIZED CONTROLLED TRIAL.

Conditions

• MALIGNANT GASTROINTESTINAL BLEEDING

Interventions

• DRUG: TC-325 monotherapy on initial endoscopy ± radiation therapy, angioembolization, and/or surgery.
• OTHER: Current standard therapy

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborators

• [object Object]